Without explaining how national means can be used to achieve desired ends, the strategy is just empty rhetoric.

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these ...

The Nutraceutical Excipients Market was valued at USD 4.5 billion in 2024, reflecting strong expansion driven by the rising consumption ...

The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...